Altimmune Inc’s recently made public that its Director Sohn Catherine A. acquired Company’s shares for reported $5784.0 on Mar 17 ’25. In the deal valued at $5.78 per share,1,000 shares were bought. As a result of this transaction, Sohn Catherine A. now holds 1,000 shares worth roughly $5320.0.
Then, WEAVER GREGORY L bought 10,000 shares, generating $51,996 in total proceeds. Upon buying the shares at $5.20, the Chief Financial Officer now owns 10,000 shares.
Before that, Drutz David sold 16,011 shares. Altimmune Inc shares valued at $110,547 were divested by the Director at a price of $6.90 per share. As a result of the transaction, Drutz David now holds 41,958 shares, worth roughly $0.22 million.
William Blair initiated its Altimmune Inc [ALT] rating to a Mkt perform in a research note published recently. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in early January with a ‘”a Buy”‘ rating. UBS began covering ALT with “Buy” recommendation on November 12, 2024. Guggenheim revised its rating on April 29, 2024. It rated ALT as “a Neutral” which previously was an “a Buy”.
Price Performance Review of ALT
On Friday, Altimmune Inc [NASDAQ:ALT] saw its stock fall -4.49% to $5.32. Over the last five days, the stock has lost -8.43%. Altimmune Inc shares have fallen nearly -26.21% since the year began. Nevertheless, the stocks have fallen -38.50% over the past one year. While a 52-week high of $11.16 was reached on 01/08/25, a 52-week low of $5.14 was recorded on 03/13/25. SMA at 50 days reached $6.24, while 200 days put it at $6.91.
Levels Of Support And Resistance For ALT Stock
The 24-hour chart illustrates a support level at 5.22, which if violated will result in even more drops to 5.13. On the upside, there is a resistance level at 5.49. A further resistance level may holdings at 5.67. The Relative Strength Index (RSI) on the 14-day chart is 39.42, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.17, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.35%. Stochastics %K at 34.64% indicates the stock is a holding.
How much short interest is there in Altimmune Inc?
A steep rise in short interest was recorded in Altimmune Inc stocks on 2025-03-14, dropping by 20079.0 shares to a total of 22.45 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 22.47 million shares. There was a decline of -0.09%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 24, 2024 when Goldman began covering the stock and recommended ‘”a Neutral”‘ rating along with a $13 price target.
